‘World-first’ gonorrhoea vaccine to be rolled out in England

A new vaccine for gonorrhea will be rolled out in England as part of a world-first program, marking a significant step toward combating the rising infection and antibiotic-resistant strains. The 4CMenB vaccine, typically used to fight meningococcal B, is being adapted for use against gonorrhea with promising efficacy rates between 32.7% to 42%. While it won't eliminate the risk entirely, officials have praised its effectiveness in reducing transmission and protecting individuals at high risk.